combination of inotuzumab and torisel ozogamycin for cancer treatment

摘要

Patent Summary: "Combination of inotuzumab and torisel ozogamycin for the treatment of cancer". The present invention relates to a therapeutic method for treating cancer comprising the use of a combination of inotuzumab ozogamycin (cmc-544) and temsirolimus. The enhanced antitumor of combination therapy is particularly useful for the patient population that is recalcitrant for inotuzumab or temsirolimus ozogamycin therapy, recurrent after treatment with inotuzumab or temsirolimus ozogamycin, or where the intensified antitumor effect reduces treatment-associated toxicities. using inotuzumab or temsirolimus ozogamycin.